Skip to main
SPRY
SPRY logo

SPRY Market Capitalization Overview

Market Cap: $851.89M as of Nov 3, 2025

$851.89M
Past Month-$167.02M (16.39%)
As of Nov 3, 2025, SPRY has a market capitalization of $851.89M. Over the past 30 days, its market cap has decreased by -14.57%, while in the last 12 months, it has decreased by -16.91%.

Market capitalization represents the total value of ARS Pharmaceuticals Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

SPRY Market Cap Formula = Stock Price * Shares Outstanding

The market cap of SPRY helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

SPRY Market Cap History

DateMarket CapChange
Nov 3, 2025$851.89M-14.57%
Oct 1, 2025$997.16M-9.26%
Sep 2, 2025$1.10B-34.87%
Aug 1, 2025$1.69B+6.77%
Jul 1, 2025$1.59B+11.27%
Jun 2, 2025$1.43B+2.22%
May 1, 2025$1.39B+13.01%
Apr 1, 2025$1.23B+24.27%
Mar 3, 2025$989.35M-17.30%
Feb 3, 2025$1.20B+14.94%
Jan 2, 2025$1.05B-19.59%

SPRY End of Year Market Cap History

DateMarket CapChange
2025$851.89M-16.91%
2024$1.03B+94.90%
2023$526.07M+71.04%
2022$307.58M+31.66%
2021$233.61M-85.51%
2020$1.62B

FAQs About ARS Pharmaceuticals Inc (SPRY) Market Cap

As of Nov 3, 2025, the market capitalization of SPRY is $851.89M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, ARS Pharmaceuticals Inc’s market capitalization has decreased by -16.39%, changing from $1.02B to $851.89M as of Nov 3, 2025.

In the last 3 months, ARS Pharmaceuticals Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, ARS Pharmaceuticals Inc’s market capitalization increased from $526.07M in January to $1.03B in December, reflecting a 94.9% change.

In the past five years, SPRY has had a compound annual growth rate (CAGR) of -8.66% in market capitalization. This means its market cap has shrunk at an average rate of -8.66% per year.

ARS Pharmaceuticals Inc (SPRY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.